MJP Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,943
| Closed | -$240K | – | 233 |
|
2025
Q1 | $240K | Buy |
+3,943
| New | +$240K | 0.04% | 187 |
|
2024
Q2 | – | Sell |
-3,702
| Closed | -$201K | – | 235 |
|
2024
Q1 | $201K | Buy |
+3,702
| New | +$201K | 0.04% | 221 |
|
2023
Q4 | – | Sell |
-4,985
| Closed | -$289K | – | 182 |
|
2023
Q3 | $289K | Sell |
4,985
-2,508
| -33% | -$146K | 0.08% | 105 |
|
2023
Q2 | $479K | Sell |
7,493
-853
| -10% | -$54.5K | 0.16% | 74 |
|
2023
Q1 | $578K | Sell |
8,346
-25
| -0.3% | -$1.73K | 0.18% | 61 |
|
2022
Q4 | $602K | Buy |
8,371
+277
| +3% | +$19.9K | 0.18% | 58 |
|
2022
Q3 | $575K | Sell |
8,094
-35
| -0.4% | -$2.49K | 0.17% | 58 |
|
2022
Q2 | $626K | Sell |
8,129
-1,393
| -15% | -$107K | 0.18% | 61 |
|
2022
Q1 | $696K | Buy |
9,522
+2,289
| +32% | +$167K | 0.17% | 59 |
|
2021
Q4 | $448K | Buy |
7,233
+190
| +3% | +$11.8K | 0.13% | 82 |
|
2021
Q3 | $417K | Sell |
7,043
-1,530
| -18% | -$90.6K | 0.14% | 80 |
|
2021
Q2 | $573K | Sell |
8,573
-93
| -1% | -$6.22K | 0.19% | 60 |
|
2021
Q1 | $547K | Buy |
8,666
+20
| +0.2% | +$1.26K | 0.22% | 55 |
|
2020
Q4 | $536K | Buy |
+8,646
| New | +$536K | 0.23% | 55 |
|